Evidence map›Paper›PMID 23958185›Full record

ArticleCell communication and signaling : CCS2013

Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits.

Selvakumar Subbian, Nirmalya Bandyopadhyay, Liana Tsenova, Paul O'Brien, Viraj Khetani, Nicole L Kushner, Blas Peixoto, Patricia Soteropoulos, Joel S Bader, Petros C Karakousis and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Mathematical modeling suggests heterogeneous replication ofbioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Exposure ofFrontiers in tuberculosis · 2024
    Article
  13. Article
  14. Article
  15. Early innate cell interactions withFrontiers in immunology · 2023
    Review
  16. Animal models for COVID-19 and tuberculosis.Frontiers in immunology · 2023
    Review
  17. Article
  18. Exploring the Role of Low-Density Neutrophils DuringFrontiers in cellular and infection microbiology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Selvakumar Subbian
Nirmalya Bandyopadhyay
Liana Tsenova
Paul O'Brien
Viraj Khetani
Nicole L Kushner
Blas Peixoto
Patricia Soteropoulos
Joel S Bader
Petros C Karakousis
Dorothy Fallows
Gilla Kaplan
Rutgers, The State University of New Jersey · USJohns Hopkins University · USHigh Throughput Biology (United States) · US

Funding

Host &Pathogen Determinants of M tuberculosis LatencyR01AI054338 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KAPLAN, GILLA · 2002 to 2011
$5.0M
A Multidisciplinary Approach to Understanding TB Latency and ReactivationR01HL106786 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BADER, JOEL S., KARAKOUSIS, PETROS C · 2010 to 2013
$3.1M
NHLBI NIH HHS R01HL106786NIAID NIH HHS AI054338NIAID NIH HHS R01 AI054338
6 · The paper itself

Abstract

backgroundPulmonary infection of humans by Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), results in active disease in 5-10% of individuals, while asymptomatic latent Mtb infection (LTBI) is established in the remainder. The host immune responses that determine this differential outcome following Mtb infection are not fully understood. Using a rabbit model of pulmonary TB, we have shown that infection with the Mtb clinical isolate HN878 (a hyper-virulent W-Beijing lineage strain) leads to progressive cavitary disease similar to what is seen in humans with active TB. In contrast, infection with Mtb CDC1551 (a hyper-immunogenic clinical isolate) is efficiently controlled in rabbit lungs, with establishment of LTBI, which can be reactivated upon treatment with immune-suppressive drugs. We hypothesize that the initial interaction of Mtb with the cells of the host response in the lungs determine later outcome of infection.

resultsTo test this hypothesis, we used our rabbit model of pulmonary TB and infected the animals with Mtb HN878 or CDC1551. At 3 hours, with similar lung bacillary loads, HN878 infection caused greater accumulation of mononuclear and polymorphonuclear leukocytes (PMN) in the lungs, compared to animals infected with CDC1551. Using whole-genome microarray gene expression analysis, we delineated the early transcriptional changes in the lungs of HN878- or CDC1551-infected rabbits at this time and compared them to the differential response at 4 weeks of Mtb-infection. Our gene network and pathway analysis showed that the most significantly differentially expressed genes involved in the host response to HN878, compared to CDC1551, at 3 hours of infection, were components of the inflammatory response and STAT1 activation, recruitment and activation of macrophages, PMN, and fMLP (N-formyl-Methionyl-Leucyl-Phenylalanine)-stimulation. At 4 weeks, the CDC1551 bacillary load was significantly lower and the granulomatous response reduced compared to HN878 infection. Moreover, although inflammation was dampened in both Mtb infections at 4 weeks, the majority of the differentially expressed gene networks were similar to those seen at 3 hours.

conclusionsWe propose that differential regulation of the inflammation-associated innate immune response and related gene expression changes seen at 3 hours determine the long term outcome of Mtb infection in rabbit lungs.

Indexed as

Immunity, InnateAnimalsInflammationLeukocytes, MononuclearMacrophagesMycobacterium tuberculosisNeutrophilsRabbitsSTAT1 Transcription FactorTime FactorsTranscriptomeTuberculosis, PulmonarySTAT1 Transcription Factor

Identifiers

PMID23958185
PMCPMC3765177
OpenAlexW2105228567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.